<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<doc>
  <docno>
    <textblock>FR940203-2-00060</textblock>
  </docno>
  <parent>
    <textblock>FR940203-2-00034</textblock>
  </parent>
  <text>
    <textblock>Pursuant to Public Law 92-463, notice is hereby given of the meeting of the Cancer Biology-Immunology Contracts Review Committee, National Cancer Institute, National Institutes of Health, on February 25, 1994, at the Executive Plaza North Building, Conference room G, 6130 Executive Boulevard, Rockville, Maryland 20892.</textblock>
    <textblock>This meeting will be open to the public on February 25 from 8:30 am to 9:30 am to discuss administrative details. Attendance by the public will be limited to space available. In accordance with provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5, U.S.C. and section 10(d) of Public Law 92-463, the meeting will be closed to the public on February 25 from 9:30 am to adjournment for the review, discussion, and evaluation of individual contract proposals. These proposals and the discussions could reveal confidential trade secrets or commercial property such as patentable material and personal information concerning individuals associated with the proposals, disclosure of which would constitute a clearly unwarranted invasion of personal privacy.</textblock>
    <textblock>Ms. Carole Frank, Committee Management Officer, National Cancer Institute, Executive Plaza North Building, room 630E, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892-9003, (301) 496-5708, will provide a summary of the meeting and a roster of the committee members upon request.</textblock>
    <textblock>Dr. Lalita D. Palekar, Scientific Review Administrator, Cancer Biology-Immunology Contracts Review Committee, 9000 Rockville Pike, room 609, Bethesda, Maryland 20892-9003, (301) 496-7575, will furnish substantive program information.</textblock>
    <textblock>Individuals who plan to attend and need special assistance such as sign language interpretation or other reasonable accommodations, should contact Ms. Alma O. Carter, (301) 496-7523 in advance of the meeting.</textblock>
    <textblock>(Catalog of Federal Domestic Assistance Program Numbers: 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control.)</textblock>
    <textblock>Dated: January 27, 1994.</textblock>
  </text>
  <usbureau>
    <textblock>National Institutes of Health</textblock>
  </usbureau>
  <doctitle>
    <textblock>National Cancer Institute; Meeting of the Cancer Biology-Immunology Contracts Review Committee</textblock>
  </doctitle>
  <signer>
    <textblock>Susan K. Feldman,</textblock>
  </signer>
  <signjob>
    <textblock>Committee Management Officer, NIH.</textblock>
  </signjob>
  <frfiling>
    <textblock>[FR Doc. 94-2454 Filed 2-2-94; 8:45 am]</textblock>
  </frfiling>
  <billing>
    <textblock>BILLING CODE 4140-01-M</textblock>
  </billing>
</doc>
